急性损伤与Polymyxin B治疗之间的关联:一个回顾性队列研究
Long Wen1, Xuefeng Yuan2, Xiaohui Liu3
1Department of Respiratory and Critical Care Medicine, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University), Changsha, Hunan, People's Republic of China.
Science progress
|September 18, 2025
概括
聚米辛B (PMB) 治疗可能导致急性损伤 (AKI). 同时的慢性病 (CKD) 和较高的PMB剂量增加了AKI风险,需要仔细监测.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 聚米辛B (PMB) 是一种关键的抗生素,用于治疗多抗药性格拉姆阴性细菌感染.
- 毒性是与PMB治疗相关的一个重大问题,可能导致急性损伤 (AKI).
- 识别PMB诱导的AKI的风险因素对于患者安全和优化治疗策略至关重要.
研究的目的:
- 分析Polymyxin B (PMB) 对毒性参数的影响.
- 确定与接受PMB的患者中AKI发展相关的变量.
- 确定PMB相关AKI的独立风险因素.
主要方法:
- 在第三级医院接受PMB治疗超过48小时的84名成年患者的回顾性研究.
- 根据KDIGO标准将患者分为AKI和非AKI组.
- 多变量物流回归分析用于识别PMB相关AKI的风险因素.
主要成果:
- 42.9%的患者患有AKI,平均发病时间为5天.
- 同时的慢性病 (CKD) (OR=5.47) 和更高的每日PMB维持剂量 (OR=12.57) 独立地与AKI相关.
- 16.7%的AKI患者需要脏替代疗法 (RRT).
结论:
- PMB治疗与AKI的显著风险有关.
- 以前存在的CKD和升高的PMB维持剂量是PMB诱导毒性的独立风险因素.
- 密切监测功能和药物水平对于安全的PMB管理至关重要.
相关概念视频
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
01:20Acute Kidney Injury V: Interprofessional Care
297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
321
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
321
01:22Acute Kidney Injury I: Introduction
581
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
581
01:29Acute Kidney Injury II: Pathophysiology
903
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
903
01:29Acute Kidney Injury III: Clinical Manifestations
827
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
827